Schonfeld Strategic Advisors LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$18,081
-68.3%
31,200
-48.0%
0.00%
Q3 2022$57,000
-20.8%
60,0000.0%0.00%
-100.0%
Q2 2022$72,000
-8.9%
60,0000.0%0.00%0.0%
Q1 2022$79,000
-94.6%
60,000
-57.8%
0.00%
-96.4%
Q3 2020$1,465,000
-37.3%
142,295
+27.1%
0.03%
-9.7%
Q2 2020$2,338,000
+1898.3%
111,994
+838.1%
0.03%
+342.9%
Q1 2020$117,000
-89.7%
11,938
-88.0%
0.01%
-75.0%
Q4 2019$1,141,000
-69.5%
99,091
-85.6%
0.03%
-74.5%
Q3 2019$3,742,000686,7000.11%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 178,654$652,0000.48%
EcoR1 Capital, LLC 762,947$2,785,0000.37%
VHCP Management II, LLC 280,000$1,022,0000.28%
MANGROVE PARTNERS IM, LLC 413,838$1,511,0000.26%
Sessa Capital IM, L.P. 638,712$2,331,0000.26%
683 Capital Management, LLC 550,000$2,008,0000.21%
Rhenman & Partners Asset Management AB 154,006$562,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 35,346$129,0000.05%
Tekla Capital Management LLC 300,078$1,095,0000.04%
Marquette Asset Management, LLC 25,998$95,0000.04%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders